Papa lab publications

Selected highlight publications

1. Lee Y, Chen M, Lee JD, Zhang J, Lin SY, Fu TM, Chen H, i Ishikawa T, Chiang SY, Katon J, Zhang Y, Shulga YV, Bester AC, Fung J, Monteleone E, Wan L, Shen C, Hsu CH, Papa A, Clohessy JG, Teruya-Feldstein J, Jain S, Wu H, Matesic L, Chen RW, Wei W, Pandolfi PP. 2019. Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitory pathway. Science, accepted.

2. Papa A*, and Pandolfi PP*. 2019. The PTEN-PI3K Axis in Cancer. Biomolecules 17;9(4)

3. Papa A, Wan L, Bonora M, Salmena L, Song MS, Hobbs RM, Lunardi A, Webster K, Ng C, Newton RH, et al. 2014. Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function. Cell 157, 595-610.

4. Liu P, Begley M, Michowski W, Inuzuka H, Ginzberg M, Gao D, Tsou P, Gan W, Papa A, Kim BM, et al. 2014. Cell-cycleregulated activation of Akt kinase by phosphorylation at its carboxyl terminus. Nature 508, 541-545.

5. Juvekar A, Burga LN, Hu H, Lunsford EP, Ibrahim YH, Balmana J, Rajendran A, Papa A, Spencer K, Lyssiotis CA, et al. 2012. Combining a PI3K inhibitor with a PARP inhibitor provides an effective therapy for BRCA1-related breast cancer. Cancer Discovery 2, 1048-1063.

Additional publications

A full list of Papa Lab publications can be viewed on her Monash research profile.